BioticsAI's AI-powered fetal abnormality detection software has been cleared by the FDA
BioticsAI, a 2023 TechCrunch Disrupt winner, has received FDA clearance for its AI software that detects fetal abnormalities in ultrasound imaging. The startup plans to expand its presence across healthcare systems in the U.S.